- Home
- LOCO vs BWAY Comparison
LOCO vs BWAY Comparison
Compare LOCO & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOCO | BWAY |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.5M | 547.7M |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | LOCO | BWAY |
|---|---|---|
| Price | $14.13 | $12.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $20.30 | $19.27 |
| AVG Volume (30 Days) | ★ 167.1K | 77.2K |
| Earning Date | 10-29-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.65 | N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $401,701,000.00 | N/A |
| Revenue This Year | $2.93 | $32.42 |
| Revenue Next Year | $4.03 | $23.40 |
| P/E Ratio | ★ $20.54 | $81.98 |
| Revenue Growth | ★ 5.68 | N/A |
| 52 Week Low | $8.99 | $11.77 |
| 52 Week High | $17.40 | $26.63 |
Technical Indicators
Market Signals| Indicator | LOCO | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 31.45 |
| Support Level | $13.52 | $11.90 |
| Resistance Level | $15.63 | $14.83 |
| Average True Range (ATR) | 0.35 | 0.55 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 32.68 | 0.61 |
Price Performance
Historical ComparisonAbout LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.